EventsThe 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Published
This submission belongs to the session S2. General of the event The 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Published date
28 Oct, 2026
Academic Editor
author-avatarThierry Vandamme
Contribution&Funding
Methodology,
[Vaishnavi Tushar Mahajan]
Formal analysis,
[Vaishnavi Tushar Mahajan]
Investigation,
[Pavan Balasaheb Udavant ]
Writing - original draft,
[Vaishnavi Tushar Mahajan]
Writing - review,
[editing] ; [Vaishnavi Tushar Mahajan]
Visualization,
[Vaishnavi Tushar Mahajan]
Supervision,
[Pavan Balasaheb Udavant ]
Project administration,
[Vaishnavi Tushar Mahajan]
Funding: --
Citation
Vaishnavi Tushar Mahajan, Pavan Balasaheb Udavant , Priya Madhukar Salunke, Development and Characterization of a High-Fat High-Sucrose Dietary Model for Experimental Hepatic Injury in Wistar Rats, in Proceedings of The 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics, 1 November–30 November 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Development and Characterization of a High-Fat High-Sucrose Dietary Model for Experimental Hepatic Injury in Wistar Rats

Pavan Balasaheb Udavant 1
1. Pharmacology , MET's Institute of Pharmacy Nashik , Nashik , 422003, India
Abstract

Background:

Excessive consumption of dietary fat and simple sugars is associated with dyslipidemia, hepatic lipid accumulation, oxidative stress and chronic inflammation, contributing to metabolic liver disease. A standardized dietary model is important for investigating diet-associated hepatic injury in preclinical research.

Objective:

This study aimed to formulate and characterize a high-fat high-sucrose (HFHS) diet and evaluate its potential to induce metabolic and hepatic alterations in Wistar rats.

Methods:

An HFHS diet pellets was formulated using selected nutritional ingredients in defined proportions and evaluated for physical and nutritional characteristics. The formulation exhibited hardness of 10.91 ± 0.28 kg/cm² and friability of 0.80 ± 0.05%. Twelve male Wistar rats were divided into normal control (n=6) and disease control (n=6) groups. The disease group received the HFHS diet for 8 weeks. Body and liver weights, liver index, lipid profile, hepatic enzymes, oxidative stress markers, inflammatory mediators and hepatic triglycerides were assessed. Liver histopathology was also performed.

Results:

HFHS-fed rats showed increased body weight, liver weight/liver index, total cholesterol, triglycerides, LDL-C, ALT, AST and ALP, with decreased HDL-C. MDA/TBARS and oxidative stress increased, whereas SOD, catalase and GSH decreased. TNF-α, IL-6 and MCP-1 levels and hepatic triglyceride accumulation were increased. Histopathology revealed hepatic steatosis, hepatocellular ballooning, inflammatory infiltration, sinusoidal dilatation, vascular congestion and focal hepatocellular necrosis.

Conclusion:

The formulated HFHS diet produced dyslipidemic, oxidative, inflammatory and histopathological alterations after 8 weeks, demonstrating its potential as a reproducible preclinical model of diet-associated hepatic injury.

Keywords
High-fat high-sucrose diet; hepatic injury; NAFLD; dyslipidemia; oxidative stress; inflammation; Wistar rats
Effect of Myelopeptide 2 on Addiction Memory in the Mouse
Phytochemical Characterization and In-Silico Prediction of Molecular Interactions of Cissus populnea Guill. & Perr. Stem Constituents: Relevance to Male Reproductive Health